Recall Record

Ridgewood, NJ, United States

Hyobin LLC recalls

1 recall recorded since 2018, most recently on 6 April 2021. 1 is listed as ongoing. Status and classification are as published by the FDA.

Recalls1
Ongoing (FDA)1
Terminated or completed0
Class I (FDA)0

Ongoing Class II Drugs

Recall started
6 April 2021
Reason
Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil.
Distribution
USA Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
D-0382-2021, D-0383-2021, D-0381-2021

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.